Mascoma Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.8K | Hold |
98
| – | – | ﹤0.01% | 282 |
|
|
2025
Q1 | $16.7K | Hold |
98
| – | – | ﹤0.01% | 280 |
|
|
2024
Q4 | $16.3K | Hold |
98
| – | – | ﹤0.01% | 296 |
|
|
2024
Q3 | $16.8K | Hold |
98
| – | – | ﹤0.01% | 279 |
|
|
2024
Q2 | $15.1K | Hold |
98
| – | – | ﹤0.01% | 289 |
|
|
2024
Q1 | $15.1K | Hold |
98
| – | – | ﹤0.01% | 278 |
|
|
2023
Q4 | $15.5K | Sell |
98
-2
| -2% | -$316 | ﹤0.01% | 288 |
|
|
2023
Q3 | $14.6K | Hold |
100
| – | – | ﹤0.01% | 296 |
|
|
2023
Q2 | $15.1K | Hold |
100
| – | – | ﹤0.01% | 290 |
|
|
2023
Q1 | $15.4K | Hold |
100
| – | – | ﹤0.01% | 367 |
|
|
2022
Q4 | $15.4K | Hold |
100
| – | – | ﹤0.01% | 365 |
|
|
2022
Q3 | $13K | Hold |
100
| – | – | ﹤0.01% | 372 |
|
|
2022
Q2 | $14K | Hold |
100
| – | – | ﹤0.01% | 382 |
|
|
2022
Q1 | $15K | Hold |
100
| – | – | ﹤0.01% | 398 |
|
|
2021
Q4 | $16K | Hold |
100
| – | – | 0.01% | 355 |
|
|
2021
Q3 | $17K | Buy |
+100
| New | +$17K | 0.01% | 306 |
|
|
2021
Q2 | – | Sell |
-100
| Closed | -$16K | – | 221 |
|
|
2021
Q1 | $16K | Buy |
+100
| New | +$16K | 0.01% | 317 |
|
|
2019
Q3 | – | Sell |
-100
| Closed | -$14K | – | 168 |
|
|
2019
Q2 | $14K | Hold |
100
| – | – | 0.01% | 246 |
|
|
2019
Q1 | $15K | Hold |
100
| – | – | 0.01% | 243 |
|
|
2018
Q4 | $12K | Hold |
100
| – | – | 0.01% | 244 |
|
|
2018
Q3 | $16K | Hold |
100
| – | – | 0.01% | 250 |
|
|
2018
Q2 | $14K | Hold |
100
| – | – | 0.01% | 252 |
|
|
2018
Q1 | $13K | Hold |
100
| – | – | 0.01% | 253 |
|
|
2017
Q4 | $14K | Hold |
100
| – | – | 0.01% | 242 |
|
|
2017
Q3 | $12K | Hold |
100
| – | – | 0.01% | 269 |
|
|
2017
Q2 | $11K | Hold |
100
| – | – | 0.01% | 278 |
|
|
2017
Q1 | $11K | Buy |
+100
| New | +$11K | 0.01% | 253 |
|